2 unknown, 1 completed, 1 recruiting, 1 suspended. 6 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Unknown 2, Completed 1, Recruiting 1, Suspended 1, Terminated 1 |
| Phase 1 | 3 | Unknown 2, Terminated 1 |
Follow Cancer of Rectum: new trials by email Literature Review of Cancer of Rectum trials Research Report on Cancer of Rectum
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunotherapy in Patients With Early dMMR Rectal Cancer Nivolumab, Ipilimumab - Cancer of Rectum | Phase 2 | Recruiting | Odense University Hospital | 39 | 2023-02-01 | 2025-08-07 |
| Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer combination of drugs (chemoradiation (capecitabine and radiation) + FOLFOXIRI (Oxaliplatin, leucovorin, irinotecan, and fluorouracil) - Cancer of Rectum | Phase 2 | Suspended | Rutgers, The State University of New Jersey | 38 | 2022-05-13 | 2025-12-04 |
| A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies Cannabidiol, Bortezomib, Leucovorin - Cancer of Pancreas, Cancer of Liver | Phase 1 / Phase 2 | Unknown | Leaf Vertical Inc. | 160 | 2019-01-15 | 2018-07-31 |
| Fluorescence Targeted Pelvic Lymph Node Mapping Indocyanine Green - Cancer of Rectum, Lymph Node Disease | Phase 1 / Phase 2 | Terminated | Oxford University Hospitals NHS Trust | 1 | 2017-08-01 | 2019-08-13 |
| Study to Nivolumab Following Preoperative Chemoradiotherapy Nivolumab, Ipilimumab - Cancer of Rectum | Phase 1 / Phase 2 | Unknown | Takayuki Yoshino | 90 | 2016-10-01 | 2021-09-16 |
| Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum Radiation, Oxaliplatin, Leucovorin - Cancer of Rectum, Cancer of the Rectum | Phase 2 | Completed | Washington University School of Medicine | 20 | 2016-05-27 | 2021-02-18 |
Rectal Neoplasms (6) · Colonic Neoplasms (1) · Gallbladder Neoplasms (1) · Glioblastoma (1) · Liver Neoplasms (1) · Multiple Myeloma (1) · Pancreatic Neoplasms (1)
Colorectal Neoplasms (6) · Digestive System Diseases (6) · Digestive System Neoplasms (6) · Gastrointestinal Diseases (6) · Gastrointestinal Neoplasms (6) · Intestinal Diseases (6) · Intestinal Neoplasms (6) · Neoplasms (6) · Neoplasms by Site (6) · Rectal Diseases (6) · Astrocytoma (1) · Biliary Tract Diseases (1) · Biliary Tract Neoplasms (1) · Blood Protein Disorders (1) · Cardiovascular Diseases (1)
Fluorouracil (3) · Leucovorin (3) · Oxaliplatin (3) · Capecitabine (2) · Chemoradiotherapy (2) · Ipilimumab (2) · Irinotecan (2) · Nivolumab (2) · Radiation (2) · Bevacizumab (1) · Bortezomib (1) · Cannabidiol (1) · Gemcitabine (1) · Indocyanine Green (1) · Temozolomide (1)
Leaf Vertical Inc. (1) · Odense University Hospital (1) · Oxford University Hospitals NHS Trust (1) · Rutgers, The State University of New Jersey (1) · Takayuki Yoshino (1) · Washington University School of Medicine (1)
United States (3) · Denmark (1) · Japan (1) · United Kingdom (1)
Chris Cunningham, MD (1) · Hyun Kim, M.D. (1) · Line S Tarpgaard, MD, Phd (1) · Patrick M Boland, MD (1) · Salma Jabbour, MD (1) · Sarah F Katta, DO (1) · Takayuki Yoshino, Dr (1) · Thomas Barnes, MBChB (1)